BlackRock’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4K | Hold |
8,504
| – | – | ﹤0.01% | 5110 |
|
|
2025
Q1 | $17.3K | Hold |
8,504
| – | – | ﹤0.01% | 5065 |
|
|
2024
Q4 | $28K | Hold |
8,504
| – | – | ﹤0.01% | 4997 |
|
|
2024
Q3 | $23.4K | Hold |
8,504
| – | – | ﹤0.01% | 4868 |
|
|
2024
Q2 | $34.6K | Hold |
8,504
| – | – | ﹤0.01% | 4876 |
|
|
2024
Q1 | $56.9K | Hold |
8,504
| – | – | ﹤0.01% | 4781 |
|
|
2023
Q4 | $40K | Sell |
8,504
-726
| -8% | -$3.41K | ﹤0.01% | 4917 |
|
|
2023
Q3 | $38.5K | Sell |
9,230
-13
| -0.1% | -$54 | ﹤0.01% | 4980 |
|
|
2023
Q2 | $29.1K | Hold |
9,243
| – | – | ﹤0.01% | 5069 |
|
|
2023
Q1 | $41K | Sell |
9,243
-26
| -0.3% | -$115 | ﹤0.01% | 5070 |
|
|
2022
Q4 | $61.4K | Sell |
9,269
-18
| -0.2% | -$119 | ﹤0.01% | 5089 |
|
|
2022
Q3 | $121K | Sell |
9,287
-52
| -0.6% | -$678 | ﹤0.01% | 5026 |
|
|
2022
Q2 | $140K | Sell |
9,339
-2,169
| -19% | -$32.5K | ﹤0.01% | 5041 |
|
|
2022
Q1 | $428K | Sell |
11,508
-103
| -0.9% | -$3.83K | ﹤0.01% | 4824 |
|
|
2021
Q4 | $667K | Sell |
11,611
-6,103
| -34% | -$351K | ﹤0.01% | 4717 |
|
|
2021
Q3 | $1.81M | Sell |
17,714
-167
| -0.9% | -$17.1K | ﹤0.01% | 4297 |
|
|
2021
Q2 | $1.74M | Sell |
17,881
-22,662
| -56% | -$2.21M | ﹤0.01% | 4268 |
|
|
2021
Q1 | $4.14M | Sell |
40,543
-885
| -2% | -$90.3K | ﹤0.01% | 3964 |
|
|
2020
Q4 | $4.08M | Buy |
41,428
+17,004
| +70% | +$1.67M | ﹤0.01% | 3712 |
|
|
2020
Q3 | $11.8M | Buy |
24,424
+449
| +2% | +$216K | ﹤0.01% | 3057 |
|
|
2020
Q2 | $18.6M | Buy |
23,975
+6,196
| +35% | +$4.81M | ﹤0.01% | 2786 |
|
|
2020
Q1 | $12.4M | Buy |
17,779
+581
| +3% | +$404K | ﹤0.01% | 2838 |
|
|
2019
Q4 | $15.8M | Buy |
+17,198
| New | +$15.8M | ﹤0.01% | 2977 |
|